Two Decades of Revolutionizing the Optics Industry: Continual Deliveries of World-Changing Custom Optical Products

For two decades, Zygo has been a tour-de-force in the optics industry, creating custom optical products that have revolutionized fields from life sciences to medical technology. Their technical competence is globally recognized and has firmly established Zygo as a trusted brand for optical metrology and fabrication.

The Zygo secret recipe combines expertise, experience, and an unyielding passion for optical innovation. Their comprehensive capabilities span the full spectrum of optical production, from conception to completion, supporting any optical product that can be envisaged.

A crucial ingredient in Zygo’s success recipe is their close collaboration with customers from the get-go. Each project kicks off with an in-depth discussion to understand the customer’s vision, their design origins, and the destination they seek. This early involvement enables Zygo to translate the customer’s aspirations into a tangible, high-performance prototype.

Beyond prototype development, Zygo’s process seamlessly transitions into production. A unique facet of Zygo’s production process is the integration of metrology throughout the entire chain. Zygo’s prowess in optical system design and development for metrology is manifested in their Zygo interferometers. These offer a diverse range of wavelengths, providing the flexibility needed to design custom metrology tools that can precisely measure and guarantee system performance as per customer requirements.

Further establishing their reliability, Zygo operates under the stringent guidelines of ISO 9001 and 13485. The latter is a testament to Zygo’s commitment to the medical industry, demonstrating their capability to produce products at the quality level expected in such a critical field.

What makes Zygo an ideal partner for researchers and manufacturers is their proven track record in optical design and assembly. Their robust design and development processes, coupled with half a century of business experience, equips them to take on complex measurement challenges that others might falter at.

Zygo leverages its exceptional interferometry expertise, available both in Middlefield and in Richmond, to ensure reliable, compliant, and cost-effective performance. Their ability to swiftly transition from specifications to prototypes, delivering high-quality outcomes on the first attempt, underscores why Zygo remains one of the most dependable partners in the industry, particularly for the medical field.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More